|
The Fox Law Firm is Reviewing Potential MEDTRONIC Claims Have you experienced severe health issues – such as heart failure - following the use of Medtronic products? Have your loved ones suffered adversely – or even died – as a result of using Medtronic products? If so, you should contact us immediately to protect your legal rights. If you or your loved ones have experienced any of these side effects you may have a claim for legal compensation. Contact The Fox Law Firm for superior legal representation. Produced by Medtronic, Inc., Sprint Fidelis Leads are cardiac electrodes that connect an implantable cardioverter-defibrillator (ICD) or a cardiac resynchronization therapy defibrillator (CRT-D) directly to the heart of the patient. ICDs and CRT-Ds are surgically implanted into the patient, and are intended to offer protection when changes in heart rhythms may occur that are interpreted by the devices as being possibly dangerous or life-threatening. If abnormal, irregular or potentially life-threatening heart rhythms are detected, the devices work by delivering an electrical shock, which has the effect of restoring a regular heart rhythm, thus preventing the patient’s heart from beating erratically, and at a dangerously fast speed. In October 2007, Medtronic, Inc. issued a statement to the effect that it was going to voluntarily suspend its worldwide distribution of the Sprint Fidelis defibrillation leads. This included four specific Sprint Fidelis Models, which were numbered as follows: 6930, 6931, 6948, and 6949. Furthermore, Medtronic informed physicians that they should no longer implant the leads in patients, and should return all their unused leads to the company. Medtronic’s actions were prompted by the potentially serious possibility of lead fractures in their products. Indeed, in a small number of patients who had been implanted with Sprint Fidelis Leads, the electronic wires at issue were shown to be prone to fracturing. Moreover, a very real and dangerous possibility existed that fracturing might result in the defibrillators delivering an unnecessary shock to the patient – or, equally serious, to not even operate at all. At the time of Medtronic’s withdrawal of its product, the Food and Drug Administration stated that some fatalities and serious injuries had been reported in which a fracture in a Sprint Fidelis Lead was considered to be a possible, or a likely, factor that contributed to the relevant death or injury. At the time of Medtronic’s recall, around 268,000 Sprint Fidelis Leads had been surgically implanted in patients on a worldwide scale, of which approximately 172,000 were in the U.S. Additional information: Medicine Net Web MD Reuters
|
